The study is the latest product of a long-term collaboration that Rimfrost established with the University of Bergen for the purpose of learning more about the biological effects and mechanisms of action of proteins and lipids derived from Antarctic krill.
An expanding body of research points to the significant benefits of tocotrienols.
Manufacturers have laid the groundwork to succeed in the fast-growing high-flavanol cocoa category, but there is work still to be done to show consumers that high-flavanol products are more than just desserts.
Do calcium supplements really increase cardiovascular risk? Here’s what the latest research says.
NattoPharma (Oslo, Norway) unveiled its latest vitamin K2 innovation yet at this year’s SupplySide West trade show: the industry’s first and only full-spectrum vitamin K2 ingredient that comprehensively provides menaquinones (MK) 6, 7, 8, and 9, all vital to heart health.
Will brands and formulators have to do better than simply offering higher concentrates in order to keep consumer interested in omega-3s supplements?
CRN Asks International Trade Commission to Reject Amarin’s Omega-3 Complaint, Citing Legal Deficiencies, Harm to Public Interest
In two filings submitted to the International Trade Commission, CRN argued that Amarin was “financially motivated” to expand its near monopoly over a subset of omega-3 products; if successful, CRN says, Amarin’s complaint would make it much more difficult and costly for consumers to access those products.
The prospective study, which included 135,335 participants, found that excessive consumption of carbohydrates is a contributing factor to total mortality.
Amarin’s Vascepa Omega-3 Drug Aims to Eliminate Dietary Supplement Competition with International Trade Commission Complaint, CRN Says
Amarin’s ITC complaint alleges that synthetically produced omega-3 products that are predominantly composed of EPA in either ethyl ester or re-esterified form are not considered “dietary ingredients” under Section 201(ff)(1) of the Federal Food Drug and Cosmetic Act, and thus, are not legal dietary supplements but unapproved new drugs.
The meta-analysis, comprising 14 randomized, controlled trials featuring 71,899 subjects, found that omega-3s EPA and DHA supplementation may reduce the risk of cardiac death by 8%, and that benefits may be even greater for subjects with elevated triglycerides or LDL cholesterol.